Jupiter Bioscience

Rediff.com » News » Jupiter Bioscience

News for Jupiter Bioscience

Business

Ranbaxy finding ways to make acquisitions work

The key strategic investments made by the erstwhile promoters of Ranbaxy Laboratories may seem to be floundering on the surface, but the Daiichi-owned company is looking at bigger engagements with......

Pharma firms look to profit from waste

Pharma companies are scouting for customers to sell the waste products, including solvents and pigments, generated in their companies. These products are used as raw materials in other industries,......

Meet Malav, the charismatic CEO of Ranbaxy

In the two years since becoming CEO, Malvinder Mohan Singh has systematically purged risk out of Ranbaxy's model. Malvinder Mohan Singh, 35, does not mind wearing a T-shirt in office - tucked in.......

Ranbaxy buys 15% stake in Jupiter Bio

Jupiter Bioscience, a manufacturer of specialised organic compounds, on Tuesday said it has allotted 14.91 per cent stake to Ranbaxy Laboratories through issue of share warrants on preferential......

Pharma intermediates mart to touch $590 m

As India emerges a hot spot for multinational pharma companies for active pharmaceutical ingredientsand research services outsourcing, the domestic pharma intermediates segment is also growing.......

Rediff News

Jupiter Bioscience

News for Jupiter Bioscience

Ranbaxy finding ways to make acquisitions work

Pharma firms look to profit from waste

Meet Malav, the charismatic CEO of Ranbaxy

Ranbaxy buys 15% stake in Jupiter Bio

Pharma intermediates mart to touch $590 m

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS